2/13/2018BeiGene Presents Preliminary Phase 1 Data on Tislelizumab in Patients ...

2/13/2018Chi-Med Enrolls 527 Patients in Pivotal Phase III FALUCA Trial of Fruq...

2/13/2018GSK's Digital Strategies for Reaching New Buyers in China

2/12/2018The Chinese Pharmaceutical Industry: Winners and Losers 2017

2/12/2018CFDA Publishes Its 2018 Legislation Plan

2/12/2018CDE Solicits Comments on the General Requirements on Batch Production ...

2/11/2018CFDA Releases List of Reference Formulations for Generic Drug Equivale...

2/9/2018Rexahn Partners with Haichang to Co-develop Liver Cancer Drug

2/9/2018Beijing Innocare Closes $55M Funding Round Led by Vivo Capital

2/9/2018CFDA Solicits Comments on Draft Provisions for Supervision and Adminis...

2/9/2018CFDA Issues Guidelines for Clinical Trials of HepB and Cerebral Ischem...

2/8/2018Recent Executive Moves

2/8/2018China's Medicine and Health Product Foreign Trade Rebounded in 2017

2/8/2018CFDA Releases Third Announcement for Excessively-Supplied Drug Product...

2/8/2018CDE Release Essential Dossier Data Requirements for PD-1/PD-L1 mAb Dru...

2/8/2018Chinese Researchers Finds New Potential Asthma Treatment

2/8/2018Roivant Sciences and ArQule Enter into License Agreement for Derazanti...

2/7/2018Review of Chinese Pharma Deals, R&D and Regulatory Developments in...

2/6/2018TaiGen's New IV Antibiotic Nemonoxacin Gets Fast Track Designation in ...

2/6/2018Xbrane Biopharma Licenses GnRH Analog Spherotide to CR Pharma in China

2/6/2018CFDA Vice Minister SUN Xianze to Leave the Agency

2/6/2018Pfizer, DL Medicine Enter Drug Discovery Partnership

2/6/2018BeiGene Announces Commercial Availability of VIDAZA (Azacitidine for I...

2/6/2018China to Step Up Surveillance of Online Drug Sales

2/6/2018South Korea's Pharmaceutical Export to China Jumped Nearly 400% in 201...

2/5/2018Shanghai AIC Penalizes U.S.-China Joint Venture for Providing Overseas...

2/5/2018Heads of CFDA and the Bitish Medicines and Healthcare Products Regulat...

2/5/2018More Provincial Governments Liberalize Non-essential Drug Use in Prima...

2/2/2018Shanghai AIC Terminates Antimonopoly Investigation of the City's GPO S...

2/2/2018Fosun-backed Shanghai Henlius Biotech Plans IPO in Hong Kong

Page:333/774 Total number of articles:23207: [First][<<] [331] [332] [333] [334] [335] [>>] [End]